412432007: Metoprolol succinate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with adrenergic receptor antagonist mechanism of action (substance)\Substance with beta adrenergic receptor antagonist mechanism of action (substance)\Beta-1 adrenergic receptor antagonist\Metoprolol succinate (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Substance with beta adrenergic receptor antagonist mechanism of action (substance)\Beta-1 adrenergic receptor antagonist\Metoprolol succinate (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Hypotensive agent (substance)\Substance with beta adrenergic receptor antagonist mechanism of action (substance)\Beta-1 adrenergic receptor antagonist\Metoprolol succinate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Amino alcohol\Alkanolamine (substance)\Propanolamine (substance)\Metoprolol succinate (substance)

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Amino alcohol\Alkanolamine (substance)\Propanolamine (substance)\Metoprolol succinate (substance)
\Organic compound\Substance with alcohol structure (substance)\Amino alcohol\Alkanolamine (substance)\Propanolamine (substance)\Metoprolol succinate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2467884011 Metoprolol succinate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2474009013 Metoprolol succinate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

29201000188119 métoprolol succinate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

825331000172115 succinate de métoprolol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Metoprolol succinate (substance)	Is a	Metoprolol (substance)	false	Inferred relationship	Some
Metoprolol succinate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Beta-1 adrenergic receptor antagonist (disposition)	true	Inferred relationship	Some
Metoprolol succinate (substance)	Is a	Propanolamine (substance)	true	Inferred relationship	Some
Metoprolol succinate (substance)	Is a	Beta-1 adrenergic receptor antagonist	true	Inferred relationship	Some
Metoprolol succinate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Metoprolol (substance)	true	Inferred relationship	Some
Metoprolol succinate (substance)	Is a	Substance with beta adrenergic receptor antagonist mechanism of action (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Metoprolol succinate 25mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Metoprolol succinate (substance)	Inferred relationship	Some
Metoprolol succinate 100mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Metoprolol succinate (substance)	Inferred relationship	Some
Metoprolol succinate 50mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Metoprolol succinate (substance)	Inferred relationship	Some
Metoprolol succinate 200mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Metoprolol succinate (substance)	Inferred relationship	Some
Adverse reaction caused by metoprolol succinate (disorder)	Causative agent (attribute)	True	Metoprolol succinate (substance)	Inferred relationship	Some	1
Metoprolol succinate 200mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Metoprolol succinate (substance)	Inferred relationship	Some
Metoprolol succinate 100mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Metoprolol succinate (substance)	Inferred relationship	Some
Metoprolol succinate 25mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Metoprolol succinate (substance)	Inferred relationship	Some
Metoprolol succinate 50mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Metoprolol succinate (substance)	Inferred relationship	Some
Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Metoprolol succinate (substance)	Inferred relationship	Some	1
Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Metoprolol succinate (substance)	Inferred relationship	Some	1
Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Metoprolol succinate (substance)	Inferred relationship	Some	1
Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Metoprolol succinate (substance)	Inferred relationship	Some	1
Product containing precisely metoprolol tartrate (as metoprolol succinate) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Metoprolol succinate (substance)	Inferred relationship	Some	1
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Metoprolol succinate (substance)	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 50 mg conventional release and prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Metoprolol succinate (substance)	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Metoprolol succinate (substance)	Inferred relationship	Some	2
Product containing precisely amlodipine (as amlodipine besilate) 2.5 milligram and metoprolol tartrate (as metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Metoprolol succinate (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2467884011	Metoprolol succinate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2474009013	Metoprolol succinate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
29201000188119	métoprolol succinate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
825331000172115	succinate de métoprolol	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module